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Abstract
Summary: Antibody repertoires reveal insights into the biology of the adaptive immune system and empower diag-
nostics and therapeutics. There are currently multiple tools available for the annotation of antibody sequences. All
downstream analyses such as choosing lead drug candidates depend on the correct annotation of these sequences;
however, a thorough comparison of the performance of these tools has not been investigated. Here, we benchmark
the performance of commonly used immunoinformatic tools, i.e. IMGT/HighV-QUEST, IgBLAST and MiXCR, in
terms of reproducibility of annotation output, accuracy and speed using simulated and experimental high-
throughput sequencing datasets.
We analyzed changes in IMGT reference germline database in the last 10 years in order to assess the reproducibil-
ity of the annotation output. We found that only 73/183 (40%) V, D and J human genes were shared between the ref-
erence germline sets used by the tools. We found that the annotation results differed between tools. In terms of
alignment accuracy, MiXCR had the highest average frequency of gene mishits, 0.02 mishit frequency and IgBLAST
the lowest, 0.004 mishit frequency. Reproducibility in the output of complementarity determining three regions
(CDR3 amino acids) ranged from 4.3% to 77.6% with preprocessed data. In addition, run time of the tools was
assessed: MiXCR was the fastest tool for number of sequences processed per unit of time. These results indicate
that immunoinformatic analyses greatly depend on the choice of bioinformatics tool. Our results support informed
decision-making to immunoinformaticians based on repertoire composition and sequencing platforms.
Availability and implementation: All tools utilized in the paper are free for academic use.
Contact: enkelejda.miho@fhnw.ch
Supplementary information: Supplementary data are available at Bioinformatics online.
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1 Introduction
Immunoinformatics has transformed the field of antibody discovery
and diagnostics (Brown et al., 2019; Kidd et al., 2014; Miho et al.,
2018; Robinson, 2015). It uses computational methods to analyze
immunological data, such as antibody repertoire data, and thus
leads to a better understanding of the immune system, disease diag-
nosis, discovery of therapeutics and vaccines (Bock and Goode,
2004; Greiff et al., 2015a; Kidd et al., 2014; Lefranc, 2014;
Robinson, 2015; Tomar and De, 2014). Immunoinformatic tools
are necessary to process, annotate and classify antibody sequences
for a precise, representative and unbiased analysis in order to obtain
informative and accurate results.
The adaptive immune system produces a diverse immune reper-
toire consisting of immunoglobulins expressed on B cells and
secreted antibodies, which recognize a variety of antigenic epitopes
against a plethora of pathogens. Each antibody is structurally com-
posed of two identical heavy (H) and two identical light chains (L),
each chain with a variable and a constant region. Diversity derives
from the somatic rearrangement of one variable (V), diversity (D)
and junction (J) gene for the heavy chain and a V and J gene for the
light chain from a large collection of V, D and J genes present in the
germline (Tonegawa, 1983). Additionally, insertions and deletions
of nucleotides and somatic hypermutations result in a theoretical di-
versity of 10140 unique antibodies (Miho et al., 2018). The variable
region is composed of three complementarity determining regions
(CDR1, CDR2 and CDR3), which are flanked by four framework
regions (FR1, FR2, FR3 and FR4) that together form the antigen-
binding pocket of the antibody. The CDR3 is the most variable re-
gion of the antibody and a significant contributor to antigen specifi-
city. Therefore, CDR3 sequence analysis is often an integral
component for antibody repertoire analysis in particular for the clas-
sification of clones (clonotyping) (D’Angelo et al., 2018; Greiff
et al., 2017; VanDyk and Meek, 1992; Xu and Davis, 2000). There
are many different definitions of clones in the context of B-cell re-
ceptor (BCR) repertoire sequencing in the literature. These defini-
tions can range from identical CDR3 amino acids (a.a.), clusters of
similar CDR3 sequences or include the entire variable region (Greiff
et al., 2015b; Hershberg and Luning Prak, 2015; Miho et al., 2018;
Nouri and Kleinstein, 2018). Unlike T-cell receptors (TCRs), B-cell
clonotyping is based on clonal lineages and is usually limited to the
heavy chain sequences due to the lesser degree of diversity present in
the light chain (Collins et al., 2008; Yaari and Kleinstein, 2015) and
because diversity in the CDR3 region of the heavy chain is sufficient
for most antibody specificities (Xu and Davis, 2000).
The general process for antibody repertoire analysis involves the
acquisition of immune high-throughput sequencing (HTS) data, filter-
ing, alignment and annotation of the sequences and analysis such as
clonotyping (Fig. 1). Briefly, after HTS data are collected, the sequen-
ces are aligned to V, (D) and J genes from a reference germline data-
base (e.g.GenBank, IMGT, VBASE2). Sequences are also annotated to
define FRs, CDRs and junction sites. Different immunoinformatic
tools may provide different options for germline reference databases,
alignment algorithms (e.g. Needleman–Wunsch, Smith–Waterman al-
gorithm) and antibody numbering schemes (e.g. Kabat, IMGT,
Chothia, Martin), which can result in differences in the analysis
(Abhinandan and Martin, 2008; Al-Lazikani et al., 1997;
Dondelinger et al., 2018; Kabat et al., 1992; Lefranc, 1997, p. 19).
Although several computational methods are available for the
alignment of full-length BCR sequences to germline V, D and J genes
and the annotation into FR and CDRs, the benchmarked tools were
selected based on their community recognition, available documen-
tation, maintenance cycles, open bugs, similarity between outputs
and annotation ability (Supplementary Tables S1 and S2). The per-
formance of these tools has not been compared in terms of accuracy
and comprehensiveness with differing germline databases, repertoire
compositions and sequencing platforms. Although the alignment
and annotation steps are critical to downstream analyses and can
dramatically impact subsequent output, it is unknown how the vari-
ous tools differ and to what extent their features impact the analyses
results. Therefore, we set out to investigate alignment and annota-
tion tools for B-cell antibody repertoire analysis. We use in silico
simulated data (where output results can be linked to known input
sequences, originated from defined germlines) and experimental
data from three commonly used HTS platforms and specifically in-
vestigate differences using six analytical metrics: germline reference
databases, percentage of productive output, alignment accuracy to
VDJ genes, annotation of CDR3 regions, sub-network analysis and
runtime efficiency.
2 Materials and methods
2.1 In silico datasets
Using IgSimulator version 2.0 alpha, we simulated human antibody
repertoires by mimicking the biological processes and incorporates
artificial error introduced by sequencing (Safonova et al., 2015).
Specifically, two immunoglobulin heavy chain datasets set to 1 mil-
lion sequences each were generated. In order to encompass antibody
repertoires of different sequence diversities, two types of repertoire
compositions were generated using different parameters. In the
simulated diverse antibody repertoire, the number of base antibody
sequences was set to 100 000 and the number of mutated antibody
sequences was set to 200 000. These parameters generate a high
number of low abundant clusters of mutated antibody sequences,
which represent a diverse antibody repertoire. For a polarized anti-
body repertoire, the number of base antibody sequences was set to
20 000 and the number of mutated antibody sequences was set to
100 000. The resulting repertoire consists of a high number of re-
petitive clusters, which represents a polarized antibody repertoire.
The final number of sequences generated by IgSimulator are
reported in Supplementary Table S3 and a list of germline genes
Fig. 1. Schematic of immuneoinformatic benchmarking analysis. Top, Left side:
Antibody repertoire data were simulated in silico using IgSimulator. Right side:
Experimental antibody repertoire data was collected from publically available datasets.
Top, Middle: Alignment and annotation of simulated and experimental sequences
were performed with the immunoinformatic tools: IgBLAST, IMGT/HighV-QUEST
and MiXCR. Bottom: Downstream analysis of the results compared: (i) the germline
databases (ii) alignment (iii) frequency of mishits of the V, D and J gene annotations
(iv) unique CDR3 overlap (v) sub-network analysis and (vi) speed of analysis
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used by IgSimulator are illustrated in Supplementary Table S5.
IgSimulator uses an incorporated default IMGT reference database
or a user-defined reference germline (Safonova et al., 2015). Further
information on IgSimulator is available in the Supplementary
Methods section. The simulated dataset is made available for down-
load as a set for the community to use: https://firebasestorage.goo
gleapis.com/v0/b/aihealthlab.appspot.com/o/public_data%2Fsimula
ted_sequences.tar.gz?alt¼media&token¼8ced1886-dd19-40ed-87c
7-ee9673bcfa23.
2.2 Experimental datasets
Publicly available datasets of human BCR repertoires were selected
to represent different sequencing platforms (Illumina MiSeq, Roche
454, Ion Torrent), sample preparation protocols, data quality and
disease status (healthy, HIV-infected and meningioma individuals)
(Supplementary Table S4). A secondary Illumina MiSeq dataset (B),
representative of a modern antibody repertoire sequencing protocols
and covers the full V, (D) and J regions was also included.
2.2.1 Illumina MiSeq Dataset A
Peripheral blood mononuclear cells (PBMCs) from a healthy human
donor (SRR611538) from the Texas Gulf Coast Regional Blood
Center were collected from whole blood and IgGþ memory B cells
were isolated (DeKosky et al., 2013). Variable heavy and light
chains were paired, amplified and sequenced on the Illumina MiSeq
platform.
2.2.2 Illumina MiSeq Dataset B
Peripheral blood was obtained from a healthy individual and B cells
were enriched (SRR4026019) (Heiden et al., 2017). RNA was reverse
transcribed using biotinlyated oligo dT primer and also incorporated
a universal priming site and a unique molecular identifier. PCR reac-
tion was performed using a pool of primers targeting the IGHA,
IGHD, IGHE, IGHG, IGHM, IGKC and IGLC regions and against
the universal primer resulting in full-length V, (D) and J regions.
Illumina specific adapters to added in a secondary PCR. Afterwards,
Illumina MiSeq 2 300 bp paired-end sequencing was performed.
2.2.4 Roche 454 dataset
PBMCs were obtained from HIV-1-infected donors enrolled in inves-
tigational review board-approved clinical protocols at the National
Institute of Allergy and Infectious Diseases (SRR924017) (Zhu et al.,
2013). RNA was extracted from 5 million PBMCs and reverse tran-
scribed to cDNA. PCR was performed using immunoglobulin gene-
specific constant region primers (encoding IgG and IgM) followed by
ligation of 454 specific adapters. Resulting libraries were sequenced
with the Roche 454 GS FLX pyrosequencing platform.
2.2.5 Ion torrent dataset
Blood was collected from human patients with benign meningiomas
and total DNA was extracted (SRR942698). Immunoglobulin spe-
cific primers were used to perform a multiplex PCR on the IgH locus
and fully rearranged IgH fragments were excised and purified for
sequencing by the Ion Torrent PGM sequencer (Gao et al., 2013).
2.3 Immunoinformatic tools
Here, we provide a brief summary of each of the immunoinformatic
tools. Additional details are provided in the Supplementary
Methods section, Table 1 and Supplementary Tables S1 and S2.
MiXCR is a bioinformatic tool that processes B- or T-cell immune
repertoire data from raw sequences to quantified clonotypes
(Bolotin et al., 2015). This involves alignment, annotation and clo-
notyping. The tool provides PCR error correction and merging of
paired-end reads. Analyses were performed using MiXCR version
3.0.5. IgBLAST can analyze both BCR and TCR (Ye et al., 2013).
This is done by annotating V, D, J regions, CDR3 identification and
mutational analysis of the variable regions using the BLAST search
algorithm. The user is required to provide germline databases.
IgBLAST v1.12 was used in the analyses. IMGT/HighV-QUEST
identifies the V, D and J genes and alleles by alignment with the
germline receptor gene and allele sequences of the IMGT germline
database (Alamyar et al., 2012; Brochet et al., 2008). This program
performs junction analysis and characterizes mutations in the vari-
able region. Analyses reported here were conducted with version
3.4.15. Abstar is a tool that comes as part of the ab[x] package of
tools for antibody NGS sequence analysis (Briney and Burton, 2018)
and it performs germline gene assignment and primary sequence
annotation. We used abstar version 0.3.3 in our analyses. The
command lines and parameter descriptions are in Supplementary
Table S9.
2.4 Germline comparisons
IMGT GENE-DB and GenBank provide users with reference germ-
lines for a variety of species and offer different choices of germline
reference databases within a species such as including orphon genes,
pseudogenes or only using productive genes. IMGT/HighV-QUEST
and IgBLAST use the IMGT reference germlines for alignment and
annotation (http://www.imgt.org/genedb/) while MiXCR uses a cus-
tomized database from GenBank. In the following, we specify the
options available for each tool, and which germlines were selected.
For analysis with IMGT/HighV-QUEST, the default FþORFþin-
frame P was chosen. Using Immcantation repository of scripts, we
obtained the IMGT reference germline FþORFþin-frame P and
used it for IgBLAST. The MiXCR built-in reference germline origi-
nating from GenBank (repseqio release v1.5) was used. IgSimulator
was used with the default IMGT reference database built-in with the
tool (reference genes are listed in Supplementary Table S5).
2.5 Changes in IMGT germline database
We have extrapolated the release updates for the Homo sapiens
germline gene reference database from IMGT (http://www.imgt.org/
IMGT_vquest/share/textes/datareleases.html) for the past 10 years.
We counted and noted the type of change as gene removed from ref-
erence, gene added to reference, allele added, sequence changes or
metadata changes (when the name or any of the descriptors changes
but not the sequence). An interactive version of the germline changes
over time for Homo sapiens and Mus musculus and the underlying
data can be found at https://github.com/aihealthlab/imgt-updates.
2.6 Alignment and CDR3 overlap analysis
For comparison of gene alignments and CDR3 overlap, IgBLAST,
IMGT/HighV-QUEST and MiXCR annotation outputs were consid-
ered raw outputs. In preprocessing, only productive, functional and
unique CDR3s are included, and out-of-frame sequences, sequences
containing premature stop codons, orphon genes, singletons
(CDR3s that only appear once), non-IgH sequences and CDR3s that
are smaller or equal to four a.a. were excluded. For IgBLAST and
IMGT/HighV-QUEST, the preprocessing is done by filtering the
annotations according to the above rules while in MiXCR, clones
Table 1. Bioinformatic tool scorecard
IMGT/
HighV-QUEST
IgBLAST MiXCR
Computational experience þþþ þ þ
Reference germline options þ þþþ þþ
Speed þ þþ þþþ
Accuracy þþ þþþ þ
Gene naming granularity þþþ (allele) þþþ (allele) þ (gene)
Reproducibility with
other tools
þþ þþþ þ
Number of unique clones þþ þþ þa
aMiXCR performs clonotyping which results in lower number of unique
clones.
Benchmarking immunoinformatic tools 3
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were exported with additional parameters (-filter-out-of-frames and
–filter-stops). In CDR3 overlap analysis, the Top 100 CDR3s are
defined as the Top 100 most frequent unique CDR3 a.a. sequences
of the preprocessed datasets. Since MiXCR and AbStar CDR3 out-
put differs from IgBLAST and IMGT/HighV-QUEST, we removed
the first cysteine (C) and last tryptophan (W) in the CDR3s, in order
to make their results comparable to the other tools.
2.7 Mishits
A gene alignment is the first gene assigned to an input sequence in the
case where multiple assignments are present. A mishit is the alignment
of a sequence to an incorrect gene, whereas a hit is the alignment of a
sequence to a correct gene (known originating germline). Genes that
have identical sequence but differing names are appropriately
renamed to avoid false mishits (Supplementary Table S7).
2.8 Sub-network analysis
Each annotated dataset was individually expressed as a network
where CDR3 sequences are nodes that are connected by a link if
they differ by one amino acid (Levenstein distance  1). The degree
of a CDR3 node is defined as the number of connections or links it
contains (number of similar CDR3 sequences). From each network,
we further analyzed the sub-networks derived from overlapping
CDR3 sequences resulting from each tool.
2.9 Runtime efficiency
The number of jobs, number of sequences in a dataset and the start
and finish times were recorded for each dataset annotation with
each tool. For IMGT/HighV-QUEST, each submission is counted as
one job.
2.9.1 Instrument
Data were processed on two machines running debian9 with the fol-
lowing specifications: (i) core i7 at 1.8 Ghz with 16 GB memory and
(ii) a core i7 at 2.8 Ghz with 12 GB memory.
3 Results
3.1 Reference germline gene databases change
frequently and share few genes
In the first step in antibody repertoire analysis, sequence reads are
aligned to a reference database of germline sequences (Fig. 1).
Choosing the appropriate reference germline database is of high
consequence, as this will determine the genes annotated and affect
downstream analyses such as clonotyping. Furthermore, any
changes made to the reference germline are also important and can
challenge analysis reproducibility. To measure the number and type
of changes to the IMGT reference germline, we extrapolated updates
made to the Homo sapiens reference germline over the last 10 years.
Figure 2A shows the cumulative number and type of changes in the
reference germline database between two dates. From the first re-
cord in IMGT in July 28, 2010 (version 201030-3) to the current
germline (February 10, 2019; version 201914-2), a total of 221
changes have occurred: nine gene removals, 37 gene additions, 98 al-
lele additions, 54 sequence changes and 23 metadata changes
(Fig. 2A, Supplementary Table S6). More recently, between
December 2, 2019 and February 4, 2019, there were six changes:
one gene addition, four allele additions, one sequence change
(Fig. 2A, Supplementary Table S6). Interestingly, there was a high
number of changes prior to 2016, with considerably less alterations
to the database thereafter. The large number of changes prior to this
date likely reflects the concurrent increase of high-throughput gene
sequencing due to technological developments and accessibility to
low-cost HTS. The lower number of changes after 2016 may reflect
a saturation of reference germline sequencing or IMGT policy
changes for gene or allele submissions. The highest percentage of
changes during this period was allele additions, which will likely
continue as technology costs decrease, sequence quality increases
and as sequencing genomes become a commonplace practice. We
also found that most of the changes (90 percentile) happened within
32 weeks and introduced at most five changes (Supplementary Fig.
S1). The average time update was every 13 weeks with an average of
four changes (Supplementary Fig. S1). A dynamic figure of changes
introduced to the human and mouse IMGT germline database is
shown here: https://aihealthlab.shinyapps.io/imgt-updates-master/.
Overall, germline updates seemed to be becoming more frequent,
regular and with few changes.
Another confounding factor in antibody repertoire analysis is the
tools’ option(s) for reference germlines. IMGT/HighV-QUEST,
IgBLAST and IgSimulator all use IMGT-based reference germlines
and MiXCR uses GenBank-based germline sequences. Even within
IMGT-based reference germlines, the time and choice of reference
germlines selected (IMGT contains several germline databases with-
in a single species) can affect annotation results through the inclu-
sions, exclusions and changes to the germline genes themselves. To
investigate the differences in the reference germline database be-
tween tools, we compared germline gene families (e.g. IGHV1),
genes (e.g. IGHV1-2), alleles (e.g. IGHV1-2*01) and nucleotide
sequences (e.g. CATTCGT) used by each tool. Of particular note,
MiXCR did not contain allele level designations. For IMGT/HighV-
QUEST, the default germline reference set was used to reflect an ag-
nostic user’s choice and the same reference germline was imple-
mented for IgBLAST. For IgSimulator and MiXCR, the built-in
germline databases were used. A comparison of the gene subgroups,
genes, alleles and sequence nucleotides demonstrated that
IgSimulator, IgBLAST, MiXCR have 55, 104 and 97 V genes in their
respective reference germline databases. All three tools share only
32% (44/137) V genes (Fig. 2B). IgSimulator, IgBLAST and MiXCR
have 4, 29 and 29 ( 3%, 21% and 21%) V genes that are tool-
specific and are not included in the other tools’ reference germlines
(Fig. 2B). This demonstrated that the choice of a particular reference
germline can influence results by the inclusion or exclusion of cer-
tain genes or alleles. Interestingly, MiXCR did not provide informa-
tion of the allele (corresponding MiXCR zero overlap because of
this reason), which can limit this tools’ application for genetic
Fig. 2. Germline analysis. (A) Overall cumulative number and types of changes at
each version release date. X-axis reports the release date and Y-axis represents the
number of changes. The different colors indicate the type of change. Red: gene re-
moval—when a gene is removed from the reference. Orange: gene addition—when
a new gene subgroup is added. Yellow: allele addition—when a new allele is added.
A gene addition here counts as an allele addition with the exception when allele add-
ition is larger e.g. adding multiple alleles for an existing subgroup. Light blue: se-
quence change—when the nucleotide (nt) sequence of a gene has been updated.
Blue: metadata change—when anything except the nucleotide sequence has been
changed: e.g. name, functionality, etc. (B) Intersection of V, D and J germlines used
in the evaluation of immunoinformatic tools separated by gene subgroup name (e.g.
IGHV1), gene name (e.g. IGHV1-18), allele name (e.g. IGHV1-18*01) and nucleo-
tide (nt) sequence. The nt Sequence panel measures the number of shared nucleotide
sequences, as identical strings, among the tools. For IgBLAST germlines are
FþORFþ in-frame P sequences downloaded with Immcantation scripts. This refer-
ence germline was also selected for IMGT/HighV-QUEST. For MiXCR the default
germline that is included in the tool was used. IgBLAST/IMGT/HighV-QUEST, or-
ange; MiXCR, green; and IgSimulator, purple
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research (Fig. 2B). We also found sequence differences among genes
represented with the same name (Fig. 2B). Considering that there
are differences within the reference germlines, if certain genes are
important for analysis, the researcher should be aware of the con-
tents of each germline as they can influence repertoire analysis
results. These germlines also change frequently so vigilance and
awareness are necessary as this may affect the reproducibility of
results.
3.2 Alignments of sequences to V, D and J genes differ
across immunoinformatic tools
Next, we compared the ability of each tool to align a given sequence
to a particular gene (V, D and J) and investigate the impact on the
results before and after preprocessing and across different sequenc-
ing platforms. Next, we compared the ability of each tool to align a
given sequence to a particular gene (V, D and J) and investigate the
impact on the results before and after preprocessing and across dif-
ferent sequencing platforms (Fig. 3). We found that while IMGT/
HighV-QUEST aligned the most sequences of the V genes in the
Illumina Miseq Dataset A (450 569 sequences) compared to MiXCR
(155 774 sequences) and IgBLAST (200 164 sequences), IMGT/
HighV-QUEST also lost a significant portion (86.9%) by prepro-
cessing compared to MiXCR (16.3%) and IgBLAST (52.8%)
(Fig. 3). This trend is also true for D and J gene annotations but
does not persist for annotation results from the MiSeq dataset B,
Roche 454 or Ion Torrent machines. With the MiSeq Dataset B,
which is more in align with modern sample preparation techniques,
37% of total V genes aligned by IgBlast were filtered out (lost) by
preprocessing, while IMGT/HighV-QUEST lost 20.6% and MiXCR
lost 10.7% which was similar to the Roche 454 dataset results. This
trend persisted for D and J genes for both datasets (Fig. 3). IgBLAST
was the only tool that was able to significantly align Ion Torrent V
gene data but most of this data (99.3%) was filtered out by prepro-
cessing: leaving only 0.7% of annotated reads after preprocessing
(Fig. 3). MiXCR and IMGT/HighV-QUEST were only able to align
a small number of sequences in the Ion Torrent dataset. These pat-
terns are consistent with D and J gene alignments for the Ion
Torrent sequencing data (Fig. 3). This may be likely due to the low
number of sequences in this dataset as well as the quality of data.
Looking at individual V, D and J genes it is evidence that there are
differences between gene alignment results between the three tools.
Overall, our results show that each tool aligns the same sequences
differently, and that alignment results also depend on the dataset
quality and sequencing platform.
3.3 MiXCR and IMGT/HighV-QUEST have the highest
mishit frequencies
The accuracy of gene annotation by the tools was assessed using
simulated human IGH sequences with differing compositions (polar-
ized and diverse). Since MiXCR does not annotate at the allele level,
the analysis was done at the gene level. We found that that there are
several gene names and allele names that contain the same nucleo-
tide sequence, of which immunoinformaticians should be aware and
are listed in Supplementary Table S7. In conjunction with a given
tool’s preference for one gene name over another, this creates further
complexity in evaluating accuracy. We found that MiXCR had the
highest frequency of V gene mishits (0.042 and 0.031) for diverse
and polarized simulated repertoire compositions. IMGT/HighV-
QUEST had the highest frequency of mishits for D (0.05) and J
(0.002) genes for diverse, and similarly for polarized (D, 0.020; J,
0.002) simulated dataset although at lower frequencies (Fig. 4A and
B). Overall, MiXCR contains higher frequencies of mishits across
repertoire compositions and genes (average frequency of mishits,
0.020) while IgBLAST has the least overall frequency of mishits
(average frequency of mishits, 0.004).
To determine if errors in gene annotations are uniformly distrib-
uted across all genes or are biased to a particular group of genes, we
analyzed the distribution of error within gene families. Surprisingly,
we found that the medians were quite low or at zero but the average
frequencies were skewed higher due to outliers in V and D genes for
each tool (Fig. 4C and D). The frequencies of J genes did not have
any outliers (Fig. 4C and D).
To further investigate which genes were the outliers, we gener-
ated heat maps to characterize misidentified genes within each rep-
ertoire composition. We found that each tool had different genes
that were misidentified within the same dataset (diverse or polar-
ized) (Supplementary Fig. S2). There were also differences in fre-
quency of incorrect annotations of the same tool with differing
repertoire compositions with the diverse repertoire having more
Fig. 3. Alignment counts for each tool with experimental datasets. We compare the
ability of each tool to align a given sequence to a particular gene (V, D and J). The
hit counts before and after preprocessing and across different platforms (Illumina
MiSeq, Roche 454 GS FLX and Ion Torrent) are shown. Preprocessing is defined as
the removal of unproductive sequences (out-of-frame sequences, sequences contain-
ing premature stop codons, orphon genes or non-IgH sequences). Sequences that are
removed by preprocessing by each tool are expressed by negative counts on the bot-
tom while remaining preprocessed data is expressed on the top by positive counts.
IgBLAST, red; MiXCR, orange; and IMGT/HighV-QUEST, blue. Only data for
genes with total annotated count above the 30th percentile is shown
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mishits than the polarized dataset (Supplementary Fig. S2).
Interestingly, V gene annotations seemed to have the least number
of genes misidentified among the three tools than D or J gene seg-
ments (Supplementary Fig. S2). MiXCR had the high frequency of
incorrectly annotating IGHV3-66 to IGHV3-53 at a frequency of
0.49 for diverse and 0.76 for polarized while IMGT/HighV-QUEST
and IgBLAST annotated them correctly 100% of the time in both
repertoires (Supplementary Fig. S2). The alignment of these two
genes is shown in Supplementary Figure S3. This pattern is also true
for gene IGHV4-4 which only correctly aligned at a frequency of
0.28 in diverse and 0.33 in polarized datasets with the exception of
IgBLAST in the diverse dataset which incorrectly aligned IGHV4-4
at a frequency of 0.003 (Supplementary Fig. S2).
In addition, IGHD7-27, a very short gene, had a lower frequency
(0.25 and 0.40) of correct alignment using IMGT/HighV-QUEST
(high mishit) compared to MiXCR (0.46 and 0.63) and IgBLAST
(0.89 and 0.76) in the diverse and polarized simulated datasets
(Supplementary Fig. S2). The small size of this gene may affect how
each tool is able to annotate it.
For J gene annotations, none of the tools exceeded a mishit fre-
quency greater than 0.01 but there was a different distribution of
misidentified genes across the different tools (Supplementary Fig.
S2). Although accuracy is a difficult metric to calculate based on the
duplication of gene sequences and the small size of some genes, we
attempted to assess how each tool performed with the same simu-
lated datasets and found that IgBLAST had on average the most ac-
curate annotations.
3.4 Wide range of unique CDR3 a.a. output overlap
among tools in annotated data, after preprocessing and
Top 100 CDR3s
Although each tool finds similar unique annotated output counts,
there is a wide range of unique CDR3 sequences shared among the
tools that varies depending on dataset and data type (e.g. annotated,
preprocessed or Top 100). In annotated output data, overlap ranges
from 10.4% to 31.9%, in preprocessed data from 4.3% to 77.6%
and within the Top 100 most frequent CDR3 sequences it ranges
from 31.9% to 77.5% between datasets.
Of these shared sequences, MiXCR in general has the highest
percentage of CDR3 sequences that are found by the other two tools
in annotated datasets (MiXCR, 21.4%; IgBLAST, 17%; and IMGT/
HighV-QUEST, 18.8%), but in preprocessed data IgBLAST is found
to have the highest percentage on average (68%). There were two
exceptions in the diverse dataset and the Illumina MiSeq B dataset
where IMGT/HighV-QUEST has the highest percentage of overlap
(of immunoinformatic). On average, the two tools that provide the
most similar CDR3 sequence outputs were IgBLAST and IMGT/
HighV-QUEST which have an overlap of 30.7% in annotated data,
12% for preprocessed and 33% for Top 100. Output from different
tools resulted in the most overlap when looking at the different data-
sets individually. This can be observed in the diverse, preprocessed
data and the Roche 454 annotated and preprocessed data where
MiXCR and IMGT/HighV-QUEST had the most overlap. IgBLAST
and MiXCR consistently had the least amount of overlap.
The tool that had the highest number of unique CDR3 sequences
that did not overlap with results from other tools was MiXCR in
annotated (70.5%), preprocessed (76.8%) and Top 100 CDR3s
(41.7%) with IgBLAST having lowest non-overlapping results at
(54.4%, 11%, and 32.3%, respectively) (Fig. 5). In order to bench-
mark resulting CDR3s, we used the tool abstar to annotate the data-
sets. Abstar annotated a high number of unique CDR3s compared
to the other tools (data not shown) but CDR3 overlap remained
low.
To investigate the cause in CDR3 overlap disparity between
tools, IMGT/HighV-QUEST and IgBLAST alignments and annota-
tions were compared. As they both used the same germline gene
sets, we can begin to quantify algorithm and alignment differences.
For IgBLAST, 6.82% (51 791/759 505) of total number of input
sequences did not have overlapping CDR3s with IMGT/HighV-
QUEST and 1.95% (14 844/759 505) for IMGT/HighV-QUEST
(Supplementary Table S8). Of these input sequences, the 1% (7735/
759 505) had the same VDJ gene segment alignment but different
CDR3 annotations suggesting the tools algorithms are likely respon-
sible for this difference (Supplementary Table S8). The contribution
of input sequences that had different VDJ gene segment alignments
resulting in different CDR3 annotations was 0.16% (1248/759 505)
(Supplementary Table S8). This suggests that this is due to different
alignment processes by each tool. This analysis suggests that align-
ment and annotation in addition to germline gene sets are contribu-
ting factors to the disparity between CDR3 a.a. overlap.
3.5 Sub-network analysis
To further benchmark each of the immunoinformatic tools, we uti-
lized sui generis sub-network analysis to measure the amount or de-
gree of similarity between the CDR3 a.a. sequences annotated by
each tool using simulated datasets. A network is built for each tool
using the preprocessed CDR3 a.a. sequences where nodes (CDR3
a.a.) are connected by links if they differ by one amino acid. The de-
gree of a CDR3 node is the number of links (or number of CDR3s)
that differ by one amino acid. We investigate the sub-networks
formed by CDR3 a.a. which are also present in other networks,
meaning the CDR3s that overlap between tools. An example of how
degrees are calculated and how networks and sub-networks are
formed can be found in Figure 6A and B. The networks for polarized
and diverse CDR3 of annotations from IgBLAST and IMGT/HighV-
QUEST and their corresponding sub-networks are shown in
Figure 6C. To further characterize the differences in annotations be-
tween the tools, the average degree of the entire networks resulted
from the annotation with each tool were compared (example of this
calculation is shown in Fig. 6A and B). The annotation networks fol-
low the expected topology (average number of degrees) for both
polarized and diverse repertoires (i.e. when average degree is
< 0.5¼diverse and > 0.5¼polarized). This is observed for all tools
(Fig. 6C and D). This indicates that our sub-network analysis
reflects the properties of the simulated repertoires and thus is a use-
ful analysis to benchmark the output of the tools.
The sub-networks of overlapping CDR3s between annotation
networks, can be differentially examined to infer which tool has a
higher repertoire diversity based on average degree in the corre-
sponding sub-network (Fig. 6D). The average degree is only changed
if the links are not shared between the annotation networks. When
comparing the average degrees of IgBLAST’s sub-networks with
Fig. 4. Frequency of annotation mishits. Top: These figures show the cumulative fre-
quency of annotation mishits of each gene (V, red; D, orange; and J, blue) per each
tool with simulated (A) diverse and (B) polarized datasets. Frequency is calculated
by dividing the number of annotation mishits (K) divided by the number of total
annotations (N) by the tool. Frequency ¼ K/N. Bottom: The boxplot panel shows
the frequency of annotation mishits per subgroup (e.g. IGHV1) within each gene for
simulated (C) diverse and (D) polarized datasets. This is calculated by dividing by
the number of mishits of a particular subgroup (W) by the total number of hits with-
in that subgroup (X). Frequency ¼ W/X. The lower and upper hinges correspond to
the first and third quartiles (the 25th and 75th percentiles)
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MiXCR and IMGT/HighV-QUEST (Fig. 6D, first row) to the aver-
age degrees of the other tools’ networks (second and third row),
IgBLAST has lower degree averages suggesting that IgBLAST has
the most diverse sub-networks (it on average has less connections or
links with similar CDR sequence nodes), IMGT/High V-QUEST se-
cond, with close diversity to IgBLAST and MiXCR last with the
least diverse sub-networks (Fig. 6D). Although MiXCR is shown to
be the least diverse sub-network, this is likely due to the clonotyping
step necessary to identify CDR3s, which the other tools do not per-
form. As shown previously in Figure 5, the sub-network analysis
also demonstrates the differences in annotation between the tools
and how datasets’ properties such as diversity can change depending
on which tool is used.
For each sub-network, we also tested for correlation between
CDR3 degrees of different tools using Pearson’s product moment
correlation coefficient (r) and Kendall’s tau (s) to investigate the
rank correlation of the degrees. The Pearson correlations (r) and
Kendall correlations (s) for all comparisons of the tools were near 0
indicating that the tools generate CDR3 repertoires that result in
networks with degree with differing connectivity (i.e. their degree
and degree ranks are not correlated among tools) (Fig. 6E). This fur-
ther demonstrates that the tools result in disparate annotation
results.
3.7 Runtime efficiency varies between tools
To ascertain the computation times for each tool, the user time for
annotation was measured for the three tools using the same input
files at varying sizes and using different numbers of jobs (Section 2).
For IMGT/HighV-QUEST one job is considered one submission and
for IgBLAST and MiXCR jobs represent number of cores in order to
account for multi-core personal computers. We calculate IMGT/
HighV-QUEST as one job per submission and assume. As shown in
Figure 7, MiXCR was the fastest to annotate all datasets while
IMGT/HighV-QUEST and IgBLAST finished the jobs at different
speeds depending on data type. This figure can also be used to calcu-
late analysis time for any user for these tools if the number of cores
and number of sequences is known.
4 Discussion
The different immunoinformatic workflows used for antibody reper-
toire analysis can lead to potentially different results. Therefore,
their use does not only impact numerous scientific results reported
in peer-reviewed articles (Shah et al., 2019), but also conclusions for
diagnostics, immunotherapy, antibody discovery and vaccine design
(Lanzavecchia et al., 2016; Maecker et al., 2012; Parola et al., 2018;
Trotta et al., 2018). Therefore, analyzing antibody sequencing data
accurately and reproducibly is of utmost importance.
Identifying genes involved in immunoglobulin (Ig) rearrange-
ment is highly important in autoimmune and malignant diseases
such as leukemia, lymphoma and rheumatoid arthritis where the
antibody repertoire can be used for classification and diagnosis
(Maecker et al., 2012; Robinson, 2015). IMGT/HighV-QUEST and
IgBLAST use the IMGT germline database while MiXCR uses a spe-
cific GenBank database for germline sequences. However, IgBLAST
and MiXCR can also include other germline databases as well, while
IMGT/HighV-QUEST is limited to the IMGT germlines. These dif-
ferent databases contain different set of VDJ genes, which can affect
all downstream results as shown in the analysis. Most novel analysis
tools are compared to standard tools but there has not been a cross-
tool and result-drive benchmarking of the most commonly used
tools as of date for antibody sequencing analysis (Bolotin et al.,
2015; Ye et al., 2013). The AIRR community is currently working
towards developing appropriate metadata fields for documenting
novel germline alleles, identifying germline genes not previously
documented by IMGT, and establishing standards for databases
incorporating IMGT, IgPdb and Vbase (Breden et al., 2017; Rubelt
et al., 2017; Ohlin et al., 2019; Vander Heiden et al., 2018).
Additionally, there is a need for standardized sample preparations,
library construction protocols, validated germline databases and
Fig. 5. Overlap of unique CDR3s. The bar graph shows the percentages of shared
CDR3 clones found by each tool as annotated outputs, preprocessed and the Top
100 frequency-based clones for each simulated and experimental dataset.
Preprocessed sequences are sequences that contain no premature stop codons, out-
of-frame sequences, CDR3 sequences are longer than five amino acids, and contain
only unique CDR3s. Percentages were calculated by dividing the number of unique
CDR3s found or shared between tools by the total number of CDR3s found by that
particular tool. Blue, all tools; red, IgBLAST; orange, IMGT/HighV-QUEST; light
teal, MiXCR; gray, IgBLAST and IMGT/HighV-QUEST; yellow, IgBLAST and
MiXCR; brown, MiXCR IMGT/HighV-QUEST
Fig. 6. Sub-network analysis. (A) Schematic of a network comparing CDR3 sequen-
ces (black dots ¼ nodes) similar to each other (connected by links ¼ lines) by one
a.a. and found by each tool exclusively or both (sub-network). (B) Example of how
CDR3 node degrees are calculated on the subnetworks and example of Pearson cor-
relation between the two tools’ degrees. (C) Example of a sub-network generated by
the comparison of two tools (IgBLAST and IMGT/HighV-QUEST) using diverse
and polarized simulated datasets (D) The shaded gray boxes represent the average
degree of the entire network for a single tool. Sub-networks may have different aver-
age degree depending on which annotation network the degree is measured: differ-
ent tools annotated CDR3s result in different degrees for the same sub-network.
Rows represent the network where the degree is measured in and the columns repre-
sent the sub-network formed by CDR3 shared in the network indicated by the corre-
sponding column name. (E) The scatterplot shows the degree value comparison by
tool. For each sub-network, we test the Pearson coefficient correlation (r) and
Kendall rank correlation coefficient (s) of the CDR3 degrees
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datasets for benchmarking. This effort has been started with the
Stanford S22 dataset but actual germline sequences are missing
while a reference exists for germline gene names (Jackson et al.,
2010).
We found that there is substantial difference between the results
from various immunoinformatic tools, which adds to the known
PCR and sequencing bias and errors. In this study, we compared
three, regularly-used immunoinformatic tools for antibody sequenc-
ing data analysis (IMGT/HighV-QUEST, IgBLAST and MiXCR)
using simulated and experimental datasets to inform users to the dif-
ferent tools available, default parameters and options, and on the
differences in analysis and research results (Table 1, Supplementary
Tables S1 and S2). First in the analysis, each antibody sequence is
aligned to all possible germline genes contained in a germline data-
base (IMGT and GenBank) using various algorithms. Due to the dif-
ferent database options (IMGT and GenBank, IgPdb and Vbase
germline sequences) and restrictions imposed by the tools, there is a
discrepancy between the analysis tools is the database of germlines
chosen by each of the tools. We also have developed a novel method
of benchmarking tools using sub-network analysis for a statistical
quantification of the differences between immunoinformatic tools,
which may be useful for benchmarking other tools. Of particular
surprise was the wide range of in CDR3 overlap between the three
tools especially in the Top 100 most frequent CDR3s as this is often
the focus on many researchers and is often used in choosing candi-
dates of antigen-specific antibody sequences (Reddy et al., 2010).
Based on our analysis, we believe this is a result of confounding fac-
tors such as germline gene selection, differences in algorithm, and
definitions (CDR3 parameters, unproductive/productive). A more
thorough and detailed examination is necessary to further define the
differences in CDR3 annotation.
Variables of which users need to be aware of prior to choosing
an immunoinformatic tool are: computational experience of user,
reference germline, time, accuracy of tool, sequencer, repertoire
composition and number of unique CDR3s identified. Novices in
immunoinformatics may greatly benefit from the ease of use in
IMGT/HighV-QUEST. If speed is an important factor, then MiXCR
would be a more appropriate choice. IgBLAST would be best if ac-
curacy is of utmost importance such as in genetic recombination
studies. In addition, if alleles are necessary IgBLAST and IMGT/
HighV-QUEST would be better choices although an allele-level
benchmarking of these two tools would be necessary. For specific
sequencer-generated data, it is important to consider the quality of
data over type of sequences as repertoire composition does not seem
to have a huge effect on misidentifications compared to the tool or
reference germline chosen given our small size. As shown in our
data, the different tools found differing CDR3s that overlap in dif-
ferent amounts. IgBLAST would be an ideal tool for reproducibility
with other tools while MiXCR would be better suited for detecting
unique CDR3 sequences not found by other tools. In general, our
data suggest that antibody sequencing analysis differ significantly
depending on the analysis tool used and there is no single tool that is
appropriate for all datasets and a summary of our findings can be
found in Table 1. We also provide a list of all currently available
tools for any type of BCR and TCR analysis (Supplementary Table
S9). In future, studies need to be designed that allow to appropriate-
ly assess different forms of bias—the use of biological controls (syn-
thetic sequences) is an option.
Although there are many B-cell repertoire analysis tools, they
often contain many shortfalls. While reviewing other immunoinfor-
matic tools, we had to face several challenges such as installation
problems, bugs in the software, lack of standard output file types or
lack/out of date documentation. The upkeep and maintenance of
immunoinformatic tools are very important for their continued use.
For the exploring the changes to the IMGT reference germline, we
developed an interactive version of germline changes for human
(Homo sapiens) and mouse (Mus musculus) which can be found at
https://aihealthlab.shinyapps.io/imgt-updates-master/.
Data quality is also very important to consider as low-quality
data results can be misrepresented leading to erroneous results. This
must be taken into account when using IgBLAST and IMGT/HighV-
QUEST as these tools do not provide a statistical summary on the
number of reads that were annotated unlike MiXCR.
Metadata for simulated datasets is unavailable because current
fields are tailored to biological sequences only. Further work is cur-
rently being done in this respect from the AIRR community (https://
www.antibodysociety.org/the-airr-community/) in order to set a
metadata standard that describes synthetic immune repertoire data
originating from simulations.
5 Conclusion
We provide a comprehensive overview and comparison of the three
most-commonly used immunoinformatic tools, IMGT/HighV-
QUEST, IgBLAST and MiXCR for antibody repertoire analysis. We
examined and compared reference germlines over time and exam-
ined the performance in terms of annotation output differences, ac-
curacy and speed using two simulated repertoires of differing
compositions and experimental datasets produced from different
sequencing platforms. Additionally, we provide guidance to novice
and experienced immune-informaticians on commonly used immu-
noinformatic tools. Our analysis results show that there is a need for
a future cohesion of immunoinformatic tools, analysis pipelines and
standards (Breden et al., 2017; Ohlin et al., 2019; Rubelt et al.,
2017; Vander Heiden et al., 2018).
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